18
total announcements
PGHL.NS · 15 min delayed
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange about the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of five years, effective from November 15, 2026, which has been approved by the shareholders at the 59th Annual General Meeting held on September 3, 2026.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 03, 2026, and informed the Exchange regarding voting results.
Procter & Gamble Health Limited
Procter & Gamble Health Limited held its 59th Annual General Meeting on September 3, 2026, through video conference, where the shareholders approved the audited financial statements, interim and final dividend, and other resolutions.
Procter & Gamble Health Limited
Procter & Gamble Health Limited held its 59th Annual General Meeting on September 3, 2026, through video conferencing. The meeting was conducted in accordance with the Ministry of Corporate Affairs and SEBI circulars. The company's financial year 2025-26 audited balance sheet and statement of profit and loss were adopted, and interim and final dividends were declared. The meeting also approved the re-appointment of Mr. S. Madhavan as Non-Executive Independent Director and ratified the remuneration payable to the Cost Auditor for the financial year 2026-27.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange about Shareholders meeting. The company has called the 59th Annual General Meeting (AGM) for the Financial Year ended March 31, 2026, scheduled on Thursday, September 3, 2026. The Annual Report and Notice of AGM have been sent to members in electronic mode, and a physical letter with a link to the report is sent to shareholders whose email address is not updated.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has revised its record date from August 21, 2026 to August 27, 2026, for the purpose of its Annual General Meeting and final dividend payment.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has announced its financial results for the first quarter ended June 30, 2026, with sales up 7% and Profit After Tax (PAT) up 45%.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with the company's board of directors approving the results. The results show a profit before exceptional items and tax of ₹97,31, ₹13,321, and ₹11,181 for the current, previous, and corresponding quarters, respectively.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has revised the date of its 59th Annual General Meeting for the Financial Year 2025-26 to September 3, 2026, and the record date for the purpose of AGM and final dividend to August 27, 2026.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the details of securities dematerialized or rematerialized during the quarter ended June 30, 2026, to the stock exchanges where the company's shares are listed.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange regarding 'Communication in respect of deduction of tax at source (TDS) on the amount of Dividend income from Procter & Gamble Health Limited (the Company)'. The company has recommended a final dividend of Rs. 45 per equity share of face value of Rs. 10 each for Company’s Financial Year 2025-26, subject to approval of the shareholders at the ensuing Annual General Meeting (AGM).
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange regarding the appointment of new sales leaders, effective July 1, 2026.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange regarding the appointment of Mr. M. Padmakar Rao as Sales Leader (North & West region) and Institutional Business Leader, effective July 01, 2026, along with other internal organizational changes.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange regarding the appointment of four new senior management personnel, effective July 1, 2026.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange regarding the appointment of Mr. Shine Matthew Sunny as Marketing Strategy and Planning leader, Commercial Excellence & E-commerce Leader of the company w.e.f. July 01, 2026.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange about Transcript and Link of Recording of Analysts/Institutional Investors Meet/Con. Call Updates.
Procter & Gamble Health Limited
Procter & Gamble Health Limited has informed the Exchange about Investor Presentation, highlighting strong FY 2025-26 performance, integrated growth strategy, and portfolio performance drives brand choice superiority.